News & Events
Sunshine Heart - $1.75 million Placement completed, $8.1 million Rights Issue announced
10 / 08 / 2009
Xenome and Axxam initiate discovery partnership focused on novel peptides against GPCR targets
05 / 08 / 2009
NUON THERAPEUTICS INC. APPOINTS PAULETTE DILLON, CHIEF BUSINESS OFFICER, AND TITO SERAFINI, CHIEF SCIENTIFIC OFFICER
09 / 07 / 2009
Nuon - AFFYMAX CEO ARLENE MORRIS JOINS NUON THERAPEUTICSâ?? BOARD OF DIRECTORS AS CHAIRPERSON
09 / 07 / 2009
Displaying records 26-50 of 59
